Complete Care Medical, Inc. Announces Agreement between Diabetes Gold, Inc. and BioTex Labs, Inc.

Diabetes Gold Expecting Dramatic Growth of Device Sales


HOUSTON, Aug. 25, 2005 (PRIMEZONE) -- Complete Care Medical, Inc. (Pink Sheets:CCMI) is pleased to announce that its wholly-owned subsidiary, Diabetes Gold, Inc., has entered into a joint marketing initiative with BioTex Labs, Inc. to recruit, support and assist the entry of small business owners into the diabetes supply industry. By providing assistance with licensure, marketing, inventory control, fulfillment and claims management, the companies will reduce the cost of business start-up to a few hundred dollars and dramatically reduce the cost of operations.

BioTex, headquartered in San Antonio, Texas, has ownership and operating affiliations with a number of major pharmaceutical and otc manufacturers, chemical and nutraceutical companies, and medical device manufacturers, located in the United States and throughout the Pacific Rim. It is focused on the importation, distribution and sales of FDA approved medical devices, nutraceuticals and generic pharmaceuticals. BioTex is the direct importer of the GlucoLeader diabetes monitoring system, which is used exclusively by Diabetes Gold.

"This is a major opportunity for Diabetes Gold to ramp up the wholesale side of its business," said J.P. Monteverde, CEO of Complete Care Medical, Inc. "Test marketing leads us to expect a minimum of 30 new start-ups monthly, with each new business supporting a census of more than 100 diabetes patients. We expect this marketing initiative to increase monthly sales of GlucoLeader test strips by at least 7,500 boxes each month and expect sales to eclipse 90,000 boxes per month within the next year.

Through its subsidiaries, Complete Care Medical, Inc. provides patients in all 50 states with lower cost alternatives for disease management, medical supplies and prescription pharmaceuticals. In addition, Complete Care Medical's discount services and medication program offers healthcare payers, healthcare providers, healthcare professionals and patients with easy access to utilization and compliance data in order to improve patient outcomes and improve quality of life.

For more information: www.ccmedicalinc.com

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this release that are "forward-looking statements" are based on current expectations and assumptions that are subject to known and unknown risks, uncertainties or other factors which may cause actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Actual results could differ materially because of factors such as: the effect of general economic and market conditions, entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, technological shifts, and delays in product development and related product release schedules, any of which may cause revenues and income to fall short of anticipated levels.

All information in this release is as of the date of this release. The Company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the Company's expectations.


            

Contact Data